Results 231 to 240 of about 184,937 (258)
Some of the next articles are maybe not open access.
Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice
Journal of Neuroscience Research, 1996Myelin/oligodendrocyte glycoprotein (MOG) is an integral membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, MOG is a primary target antigen involved in immune-mediated demyelination.
P A, Ballenthin, M V, Gardinier
openaire +2 more sources
Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily
Journal of Neuroscience Research, 1992AbstractMyelin/oligodendrocyte glycoprotein (MOG) is a primary target autoantigen in experimental autoimmune encephalomyelitis, a widely used animal model for autoimmune demyelinating diseases such as multiple sclerosis. We have isolated several rat MOG cDNAs and confirmed their identity by comparision with MOG N‐terminal peptide sequence. As expected,
Gardinier MV +3 more
openaire +3 more sources
Annals of Neurology, 2019
To compare response to rituximab (RTX) between adult patients positive for myelin oligodendrocyte glycoprotein (MOG) and aquaporin‐4 (AQP4) antibodies.
Pierre Durozard +10 more
semanticscholar +1 more source
To compare response to rituximab (RTX) between adult patients positive for myelin oligodendrocyte glycoprotein (MOG) and aquaporin‐4 (AQP4) antibodies.
Pierre Durozard +10 more
semanticscholar +1 more source
Current Opinion in Neurology, 2019
PURPOSE OF REVIEW To review the clinical characteristics, radiological manifestations and treatment of myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) optic neuritis. RECENT FINDINGS Serum antibodies to MOG (MOG-IgG) have recently been
John J. Chen, M. Bhatti
semanticscholar +1 more source
PURPOSE OF REVIEW To review the clinical characteristics, radiological manifestations and treatment of myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) optic neuritis. RECENT FINDINGS Serum antibodies to MOG (MOG-IgG) have recently been
John J. Chen, M. Bhatti
semanticscholar +1 more source
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases
Neurology, 2019Objective To determine the diagnostic relevance of myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) in CSF of seronegative cases by retrospectively analyzing consecutive time-matched CSF of 80 MOG-Ab–seronegative patients with demyelinating ...
S. Mariotto +13 more
semanticscholar +1 more source
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies
Current Opinion in NeurologyPurpose of review The clinical landscape associated to myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) has undergone a remarkable transformation over the past two decades, primarily driven by advancements in antibody detection techniques that have enhanced both the specificity and sensitivity of assays, enabling the ...
Elisabeth, Maillart +2 more
openaire +2 more sources
[Myelin Oligodendrocyte Glycoprotein Antibody Associated Disorders].
Brain and nerve = Shinkei kenkyu no shinpo, 2023The antibody against myelin oligodendrocyte glycoprotein (MOG) has been identified for its association with several clinical phenotypes including acute or multiphasic disseminated encephalomyelitis, optic neuritis, NMOSD, and brainstem or cerebral cortical encephalomyelitis, and now generally called MOG associated disorders (MOGAD).
openaire +1 more source
Preretinal Hemorrhage in Myelin Oligodendrocyte Glycoprotein–Associated Disease
Ophthalmology Retina, 2023Rasika Sudharshan +2 more
openaire +2 more sources